Azenta's Q3: Mixed Results in Life Sciences

Azentas Q3 2025 results showed a 5.5% revenue increase to $159.2M, surpassing estimates by 1.6%. Despite a free cash flow drop, the companys Sample Management segment continues to grow. Analysts predict a 4.1% revenue increase over the next year, with improved operating margins at 1.2%.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.